Hua Xing Zhu

Chief Executive Officer at NOVOPROTEIN SCIENTIFIC INC.

52 year

Retail Trade

Consumer Services

Commercial Services

Profile

Hua Xing Zhu is the founder and currently holds the position of Chairman & General Manager at Novoprotein Scientific (Shanghai), Inc. He founded Suzhou Novoprotein Scientific Co., Ltd.
in 2009 and holds the position of Chairman & General Manager.
Dr. Zhu received his doctorate degree from Fudan University in 2005.

Hua Xing Zhu active positions

Companies	Position	Start
NOVOPROTEIN SCIENTIFIC INC.	Chief Executive Officer	2009-09-06
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Chief Executive Officer	-

All active positions of Hua Xing Zhu

Training of Hua Xing Zhu

Fudan University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hua Xing Zhu's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVOPROTEIN SCIENTIFIC INC.	Commercial Services

Private companies	1
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Retail Trade